The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL

"Focus on..." session: lymphoma in the elderly

(2011)   ANNALS OF ONCOLOGY

Randomized comparison of pegfilgrastim day 4 versus day 2 for the prevention of chemotherapy-induced leukocytopenia

(2011) C. Zwick et al.   ANNALS OF ONCOLOGY

The impact of Fc-  receptor polymorphisms in elderly patients with diffuse large B-cell lymphoma treated with CHOP with or without rituximab

(2011) M. Ahlgrimm et al.   BLOOD

The effects of age and gender on the pharmacokinetics and pharmacodynamics in healthy subjects of the plasminogen activator, lanoteplase

(2011) Nimish N. Vachharajani et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Unraveling the Molecular Pathophysiology of Myelodysplastic Syndromes

(2011) Rafael Bejar et al.   JOURNAL OF CLINICAL ONCOLOGY

Rituximab

(2010) Gillian M. Keating   DRUGS

Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era

(2010) Christian Gisselbrecht et al.   JOURNAL OF CLINICAL ONCOLOGY

Pharmacokinetics of rituximab associated with CHOP chemotherapy in B-cell non-Hodgkin lymphoma

(2009) Hélène Blasco et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

(2008) Michael Pfreundschuh et al.   LANCET ONCOLOGY